Oncimmune (ONC) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

GBX 28

-1.10 (-3.78%)

(As of 01:43 PM ET)

Stock Analysis Chart Competitors Headlines Insider Trades

Source

Source	Headline
	Oncimmune Holdings PLC wsj.com - March 19 at 4:44 PM
	Oncimmune Holdings Full Year 2023 Earnings: UK£0.085 loss per share (vs UK£0.13 loss in FY 2022) finance.yahoo.com - March 2 at 4:43 AM
	Cancer test firm Freenome raises $254 mln in fresh funding reuters.com - February 15 at 7:56 AM
	Activist investor Kelso gains board seats at The Works as it tries to enhance shareholder value msn.com - February 14 at 10:49 AM
	Oncimmune seeing commercial traction as it inks new deals with big pharma companies proactiveinvestors.com.au - December 2 at 8:51 AM
	The Unique Use of Liquid Biopsy yahoo.com - September 26 at 9:29 AM
	Oncimmune's Acting CEO Ron Kirschner Steps Down, Takes COO Role; Gouldstone Starts as CEO marketwatch.com - August 1 at 7:22 PM
	Oncimmune Shares Fall As Company Lowers FY 2022 Revenue Result marketwatch.com - July 14 at 12:36 PM
	Oncimmune names chief executive successor, while finance chief leaves lse.co.uk - July 12 at 8:31 AM
	Oncimmune Holdings Appoints Martin Gouldstone CEO; CFO Matthew Hall to Step Down marketwatch.com - July 12 at 8:31 AM
	Oncimmune Holdings shakes up leadership and unveils new growth plan lse.co.uk - June 23 at 8:29 AM
	Oncimmune CEO Adam Hill to Step Down; Sees Tough End to FY 2023 marketwatch.com - June 23 at 8:29 AM
	Oncimmune shares plummet as interim revenue falls by fifth lse.co.uk - May 31 at 10:08 AM
	Oncimmune Shares Fall on 1H Pretax Loss marketwatch.com - May 31 at 10:08 AM
	Oncimmune sells two subsidiaries to Freenome for GBP13 million lse.co.uk - May 22 at 9:56 AM
	FREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTD markets.businessinsider.com - May 22 at 9:56 AM
	Oncimmune Eases Going-Concern Risk With Sale of Two Subsidiaries for GBP13 Mln marketwatch.com - May 22 at 9:56 AM
	The Comprehensive Guide to the Cancer Biopsy Market: Trends and Revenue Forecast with predicted CAGR of 4.2% from 2023-2030 marketwatch.com - April 28 at 12:56 PM
	Cancer Biopsy Market Outlook by 2031 marketwatch.com - April 22 at 8:06 AM
	Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference finance.yahoo.com - April 12 at 7:46 AM
	Oncimmune delivering top-line growth proactiveinvestors.com - February 28 at 5:13 AM
	Oncimmune Shares Fall After Going Concern Warning, Pretax Loss marketwatch.com - February 27 at 7:10 AM
	CORRECT: Oncimmune works with Siemens Healthineers on cancer therapy lse.co.uk - February 20 at 8:45 AM
	Richard Sharp: BBC chair was shareholder in firm awarded £600k while he was a No 10 adviser theguardian.com - January 25 at 7:39 PM
	Investors in Oncimmune Holdings (LON:ONC) have unfortunately lost 67% over the last year finance.yahoo.com - January 2 at 12:28 PM
	Oncimmune Holdings to Raise at Least GBP2.1 Mln; Mulls EarlyCDT IPO marketwatch.com - December 7 at 3:53 PM
	Institutional investors own a significant stake of 48% in Oncimmune Holdings plc (LON:ONC) finance.yahoo.com - October 13 at 12:27 PM
	Oncimmune shares plummet as company reports widened pretax loss lse.co.uk - September 21 at 10:43 AM
	Oncimmune FY 2022 Pretax Loss Widens on Higher Costs; Shares Fall marketwatch.com - September 21 at 5:41 AM
	Oncimmune Holdings Plc (ONC.L) uk.finance.yahoo.com - September 2 at 6:56 PM
	Estimating The Fair Value Of Oncimmune Holdings plc (LON:ONC) finance.yahoo.com - July 31 at 9:54 AM
	Further weakness as Oncimmune Holdings (LON:ONC) drops 12% this week, taking one-year losses to 56% finance.yahoo.com - June 16 at 3:32 AM
	Global Cancer Biopsy Market to Reach USD 43,692 Million \| Growing at CAGR of 10.7% \| Insights and Tools and Forecast 2028 benzinga.com - June 2 at 8:19 PM
	Oncimmune receives 2022 Queen's Award for Enterprise proactiveinvestors.com.au - April 21 at 8:47 AM
	FTSE 100 ends the week higher as Wall Street also recovers proactiveinvestors.com.au - April 8 at 3:15 PM
	FTSE follows US rally while Elon Musk faces potential SEC probe and UK starting salaries rise proactiveinvestors.com - April 8 at 3:15 PM
	Oncimmune agrees two new commercial contracts lse.co.uk - April 8 at 3:15 PM
	Oncimmune lands follow-on Covid study contract proactiveinvestors.com.au - March 7 at 7:21 AM
	Oncimmune Holdings Wins Follow-On Contract for Covid-19 Study marketwatch.com - March 7 at 7:21 AM
	Oncimmune 1H Pretax Loss Widened as Covid-19 Restrictions Ease marketwatch.com - February 28 at 9:39 AM
	Oncimmune Signs Contract With Verily Life Sciences to Investigate Long-Covid morningstar.com - February 28 at 4:38 AM
	Oncimmune Holdings's Lung Blood Test to Be Used in Spanish Region marketwatch.com - February 17 at 7:04 AM
	Oncimmune lung cancer diagnostic receives regulatory green light from second Spanish regional health authority proactiveinvestors.com - February 17 at 7:04 AM
	Oncimmune Hldgs PLC : Results from COVID-19 autoantibody profiling panel markets.businessinsider.com - January 4 at 10:29 AM
	Oncimmune study suggests antibodies spike following Covid infection lse.co.uk - December 31 at 9:47 AM
	Oncimmune Hldngs PLC : Grant of Options and PDMR Dealing markets.businessinsider.com - December 26 at 11:57 PM
	Oncimmune Hldngs PLC : ImmunoINSIGHTS commercial update markets.businessinsider.com - December 22 at 9:51 AM
	Oncimmune Hldngs PLC : PDMR Dealing markets.businessinsider.com - December 22 at 9:51 AM
	Oncimmune shares up after multiple commercial contract wins lse.co.uk - December 21 at 1:17 PM
	Oncimmune Signs Deal With Major Pharma Company to Provide Autoantibody Biomarker Services marketwatch.com - December 21 at 8:17 AM

Get Oncimmune News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ONC Media Mentions By Week

ONC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONC
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

ONC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONC Articles
This Week
▼
0

0
▲
ONC Articles
Average Week

Get Oncimmune News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (LON:ONC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oncimmune (ONC) News Today

ONC Media Mentions By Week

ONC Media Sentiment

ONC News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info